LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

CHARACTERIZATION OF DUVELISIB IN PATIENTS WITH REFRACTORY MARGINAL ZONE LYMPHOMA: DATA FROM THE PHASE 2 DYNAMO TRIAL

Photo by sorasagano from unsplash

S312 IBCL-025 Standardized Uptake Value Calculated from In-Ibritumomab Tiuxetan SPECT/CT is a Very Useful Predictor for Therapeutic Efficacy and Post-Treatment Neutropenia in Patients Treated by Y-IT Ayaka Kume , Akira… Click to show full abstract

S312 IBCL-025 Standardized Uptake Value Calculated from In-Ibritumomab Tiuxetan SPECT/CT is a Very Useful Predictor for Therapeutic Efficacy and Post-Treatment Neutropenia in Patients Treated by Y-IT Ayaka Kume , Akira Toriihara, Ryo Shimizu, Naoki Harata, Jun Isogai, Hiroaki Tanaka Department of Hematology, Asahi General Hospital, Chiba, Japan; PET Imaging Center, Asahi General Hospital, Chiba, Japan; Department of Radiology, Asahi General Hospital, Chiba, Japan

Keywords: general hospital; chiba japan; characterization duvelisib; hospital chiba; asahi general; duvelisib patients

Journal Title: Hematological Oncology
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.